Hjem › Urotelial (overgangscelle) karcinom › Louisiana
Kliniske studier for Urotelial (overgangscelle) karcinom i Louisiana
4 studier for Urotelial (overgangscelle) karcinom søker deltakere på steder i Louisiana.
Byer i Louisiana
Offisiell studietekst (engelsk)
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
- Louisiana Hematology Oncology Associates LLC, Baton Rouge
- Mary Bird Perkins Cancer Center - Metairie, Metairie
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT06524544Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Louisiana Hematology Oncology Associates LLC, Baton Rouge
- Northshore Oncology Associates-Covington, Covington
- Mary Bird Perkins Cancer Center - Metairie, Metairie
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 30. sep. 2026 · NCT03866382A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
- Mary Bird Perkins Cancer Center, Baton Rouge
- Mary Bird Perkins Cancer Center - Metairie, Metairie
- Ochsner Clinic Foundation, New Orleans
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT07218380SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Orleans
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 28. okt. 2025 · NCT03452774Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.